11:44 AM EST - Cardiol Therapeutics Inc. : Announced today the publication of research in the Journal of the American College of Cardiology: Basic to Translational Science, titled "Cannabidiol Prevents Heart Failure Dysfunction and Remodeling Through Preservation of Mitochondrial Function and Calcium Handling". Cardiol Therapeutics Inc.
shares T.CRDL are trading up $0.03 at $1.77.
